GLOBUS MEDICAL, INC. Revenue, Net (Deprecated 2018-01-31)
GLOBUS MEDICAL, INC. (GMED) reported Revenue, Net (Deprecated 2018-01-31) of $174.41 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2018-05-03
- GLOBUS MEDICAL, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $174.41M, a 11.94% increase year-over-year.
- GLOBUS MEDICAL, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $176.03M, a 16.13% increase year-over-year.
- GLOBUS MEDICAL, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $151.74M, a 11.86% increase year-over-year.
- GLOBUS MEDICAL, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $152.39M, a 10.84% increase year-over-year.
- GLOBUS MEDICAL, INC. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $635.98M, a 12.76% increase from fiscal 2016.
- GLOBUS MEDICAL, INC. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $563.99M, a 3.53% increase from fiscal 2015.
- GLOBUS MEDICAL, INC. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $544.75M, a 14.84% increase from fiscal 2014.
- GLOBUS MEDICAL, INC. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $474.37M, a 9.19% increase from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $174.41M 10-Q · filed 2018-05-03 | $350.44M derived: sum of 2 quarters · filed 2018-05-03 | $502.19M derived: sum of 3 quarters · filed 2018-05-03 | $654.58M derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-12-31 | $176.03M 10-K · filed 2018-02-22 | $327.78M derived: sum of 2 quarters · filed 2018-02-22 | $480.17M derived: sum of 3 quarters · filed 2018-02-22 | $635.98M 10-K · filed 2018-02-22 |
| 2017-09-30 | $151.74M 10-K · filed 2018-02-22 | $304.13M derived: sum of 2 quarters · filed 2018-02-22 | $459.94M 10-Q · filed 2017-11-09 | $611.53M derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-06-30 | $152.39M 10-K · filed 2018-02-22 | $308.20M 10-Q · filed 2017-08-03 | $459.79M derived: sum of 3 quarters · filed 2018-05-03 | $595.44M derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-03-31 | $155.81M 10-Q · filed 2018-05-03 | $307.40M derived: sum of 2 quarters · filed 2018-05-03 | $443.05M derived: sum of 3 quarters · filed 2018-05-03 | $580.54M derived: sum of 4 quarters · filed 2018-05-03 |
| 2016-12-31 | $151.59M 10-K · filed 2018-02-22 | $287.24M derived: sum of 2 quarters · filed 2018-02-22 | $424.73M derived: sum of 3 quarters · filed 2018-02-22 | $563.99M 10-K · filed 2018-02-22 |
| 2016-09-30 | $135.65M 10-K · filed 2018-02-22 | $273.14M derived: sum of 2 quarters · filed 2018-02-22 | $412.40M 10-Q · filed 2017-11-09 | $554.99M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $137.49M 10-K · filed 2018-02-22 | $276.75M 10-Q · filed 2017-08-03 | $419.34M derived: sum of 3 quarters · filed 2018-02-22 | $556.33M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $139.26M 10-K · filed 2018-02-22 | $281.85M derived: sum of 2 quarters · filed 2018-02-22 | $418.84M derived: sum of 3 quarters · filed 2018-02-22 | $552.41M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $142.59M 10-K · filed 2017-03-16 | $279.58M derived: sum of 2 quarters · filed 2017-03-16 | $413.15M derived: sum of 3 quarters · filed 2017-03-16 | $544.75M 10-K · filed 2018-02-22 |
| 2015-09-30 | $136.99M 10-K · filed 2017-03-16 | $270.56M derived: sum of 2 quarters · filed 2017-03-16 | $402.17M 10-Q · filed 2016-11-09 | $530.97M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $133.57M 10-K · filed 2017-03-16 | $265.17M 10-Q · filed 2016-07-27 | $393.98M derived: sum of 3 quarters · filed 2017-03-16 | $511.76M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $131.60M 10-K · filed 2017-03-16 | $260.40M derived: sum of 2 quarters · filed 2017-03-16 | $378.19M derived: sum of 3 quarters · filed 2017-03-16 | $491.76M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $128.80M 10-K · filed 2016-02-29 | $246.59M derived: sum of 2 quarters · filed 2016-02-29 | $360.16M derived: sum of 3 quarters · filed 2016-02-29 | $474.37M 10-K · filed 2017-03-16 |
| 2014-09-30 | $117.79M 10-K · filed 2016-02-29 | $231.36M derived: sum of 2 quarters · filed 2016-02-29 | $345.57M 10-Q · filed 2015-11-04 | $460.81M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $113.57M 10-K · filed 2016-02-29 | $227.78M 10-Q · filed 2015-07-31 | $343.03M derived: sum of 3 quarters · filed 2016-02-29 | $450.21M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $114.21M 10-K · filed 2016-02-29 | $229.46M derived: sum of 2 quarters · filed 2016-02-29 | $336.64M derived: sum of 3 quarters · filed 2016-02-29 | $443.65M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $115.25M 10-K · filed 2015-02-26 | $222.43M derived: sum of 2 quarters · filed 2015-02-26 | $329.44M derived: sum of 3 quarters · filed 2015-02-26 | $434.46M 10-K · filed 2016-02-29 |
| 2013-09-30 | $107.19M 10-K · filed 2015-02-26 | $214.20M derived: sum of 2 quarters · filed 2015-02-26 | $319.21M 10-Q · filed 2014-10-31 | $419.75M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $107.01M 10-K · filed 2015-02-26 | $212.03M 10-Q · filed 2014-08-06 | $312.56M derived: sum of 3 quarters · filed 2015-02-26 | $407.33M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $105.02M 10-K · filed 2015-02-26 | $205.55M derived: sum of 2 quarters · filed 2015-02-26 | $300.32M derived: sum of 3 quarters · filed 2015-02-26 | $396.30M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $100.54M 10-K · filed 2014-03-14 | $195.30M derived: sum of 2 quarters · filed 2014-03-14 | $291.28M derived: sum of 3 quarters · filed 2014-03-14 | $385.99M 10-K · filed 2015-02-26 |
| 2012-09-30 | $94.76M 10-K · filed 2014-03-14 | $190.74M derived: sum of 2 quarters · filed 2014-03-14 | $285.46M 10-Q · filed 2013-10-31 | $373.45M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $95.98M 10-K · filed 2014-03-14 | $190.69M 10-Q · filed 2013-08-02 | $278.69M derived: sum of 3 quarters · filed 2014-03-14 | $362.96M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $94.72M 10-K · filed 2014-03-14 | $182.71M derived: sum of 2 quarters · filed 2014-03-14 | $266.98M derived: sum of 3 quarters · filed 2014-03-14 | $347.92M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $87.99M 10-K/A · filed 2013-06-13 | $172.26M derived: sum of 2 quarters · filed 2013-06-13 | $253.20M derived: sum of 3 quarters · filed 2013-06-13 | $331.48M 10-K · filed 2014-03-14 |
| 2011-09-30 | $84.27M 10-K/A · filed 2013-06-13 | $165.21M derived: sum of 2 quarters · filed 2013-06-13 | $243.49M 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $80.94M 10-K/A · filed 2013-06-13 | $159.22M 10-Q/A · filed 2012-09-19 | ||
| 2011-03-31 | $78.28M 10-K/A · filed 2013-06-13 | |||
| 2010-12-31 | $288.19M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |